Sanara Medtech Inc at Tarsier Capital Management MicroCap Leadership Summit (Virtual) Transcript
Sanara MedTech is a wound care products and technology company. To date, the company has been growing around 40% per year with 90% gross margins, primarily due to a product called CellerateRX. The company is in the process of launching several other products. Sanara's goal is to develop a wound care telehealth offering that is the first of its kind to address the whole continuum of wound -- of care in wounds. We're honored to have Ron Nixon with us, also Callon. Ron is the Executive Chairman and also the largest shareholder of Sanara MedTech. (Operator Instructions) Ron, you can take it from there.
Thank you very much, Ian. We appreciate the opportunity to present this morning. So thank you very much. So as Ian mentioned, Sanara MedTech is a relatively new company that is -- that has been designed to disrupt what has been a very fragmented market that has not been coordinated before anything outside of the fee-for-service market. We'll talk more about that as we move
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
